Apheresis in Thoracic Organ Transplantation
- 1 February 1999
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis
- Vol. 3 (1) , 34-39
- https://doi.org/10.1046/j.1526-0968.1999.00137.x
Abstract
The beneficial addition of cyclosporine and tacrolimus to the immunosuppressive armamentarium have unfortunately only partially solved the problems of acute and chronic rejection in thoracic organ transplantation. Apheresis techniques offer creative avenues for modifications of allograft rejection. Plasmapheresis can be used for mechanical reduction of alloantibody burdens in highly sensitized patients and permit transplantation in an otherwise almost hopeless situation and can also be used on a short‐term basis for the treatment of acute humoral rejection. Extracorporeal photochemotherapy holds promise as a possibly synergistic adjunct to conventional therapy and may even reduce the severity of graft vasculopathy. The increasing availability of highly specific column immunoadsorption techniques may further increase the applicability of apheresis in transplantation.Keywords
This publication has 5 references indexed in Scilit:
- Plasmapheresis Followed by Intravenous Immunoglobulin in Presensitized Patients Awaiting Thoracic Organ TransplantationTherapeutic Apheresis, 1997
- UTILIZATION OF INTRAVENOUS IMMUNOGLOBULIN TO AMELIORATE ALLOANTIBODIES IN A HIGHLY SENSITIZED PATIENT WITH A CARDIAC ASSIST DEVICE AWAITING HEART TRANSPLANTATIONTransplantation, 1996
- INTRAVENOUS IMMUNOGLOBULIN SUPPRESSION OF HLA ALLOANTIBODY IN HIGHLY SENSITIZED TRANSPLANT CANDIDATES AND TRANSPLANTATION WITH A HISTOINCOMPATIBLE ORGANTransplantation, 1994
- REDUCTION OF THE INCIDENCE OF REJECTION BY ADJUNCT IMMUNOSUPPRESSION WITH PHOTOCHEMOTHERAPY AFTER HEART TRANSPLANTATIONTransplantation, 1994
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993